The Department of Pediatrics at Memorial Sloan Kettering Cancer Center offers a one-to-two-year post-specialty clinical and research fellowship program intended for physicians trained in pediatric hematology-oncology who seek in-depth exposure to tumor immunotherapy. The goal of this fellowship program is to train the fellow to translate immunotherapy strategies from the laboratory to the patient, including but not limited to clinical trial design, protocol development, Investigational New Drug (IND) application, and execution of clinical trials. The clinical focus will primarily be neuroblastoma, with occasional overlap with sarcoma, brain tumors and certain leukemias. Applicants for this program must have completed their residency training in pediatrics, plus fellowship training in pediatric hematology/oncology or pediatric neuro-oncology.

Deadline

Ongoing

Length of Program

One to Two Years

Eligibility

Applicants should have completed training in an ACGME-accredited Pediatric Hematology-Oncology Fellowship Program and must have completed USMLE Steps I, II, and III. Foreign medical graduates with equivalent qualifications are also eligible to apply and must have completed all three of the USMLE examinations, a CSA exam, and hold a valid ECFMG certificate. For further information and application, please contact David Meni.

How to Apply

Applicants must submit a curriculum vitae, a personal statement and three references via the MSK Applicant Portal. Please make sure to follow the instructions listed on the portal in order to successfully submit your application. Once you have submitted your application, please notify Fatima Fermin, [email protected].